Clinical Trials Directory

Trials / Completed

CompletedNCT05293262

Endourological Management of Stones During COVID19

Definitive Endourological Interventions for Urolithiasis Management During COVID19- Outcomes From a Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
158 (actual)
Sponsor
Roxanne Teo · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression. At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS). We aim to report our experience with endourological surgery for stone disease during COVID-19.

Detailed description

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndourological surgeryIncludes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Timeline

Start date
2020-01-23
Primary completion
2020-08-31
Completion
2020-08-31
First posted
2022-03-24
Last updated
2022-03-24

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05293262. Inclusion in this directory is not an endorsement.